Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population
PLOS ONE · 2023
DOI: 10.1371/journal.pone.0288139 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Assiya Yessenbayeva und 8 weiteren Autor:innen. Beteiligte Einrichtung: Medical University Semey, Semey, Republic of Kazakhstan. Hauptthemen laut MEDLINE: COVID-19, Hemostatics. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objectives
To study the role of biological markers of immunothrombosis and polymorphisms of cytokine genes IL2 , IL6 , IL10 and their influence on the severity of COVID-19 in a Kazakh population.
Methods
A total of 301 patients of Kazakh nationality with a confirmed diagnosis of COVID-19 participated in the retrospective study, including 142 patients with severe and 159 with a mild course. Single nucleotide polymorphisms IL2R rs1801274, IL6 rs2069840, and IL10 rs1800872 were genotyped by real-time PCR. Activated partial thromboplastin time, normalized ratio, prothrombin index, prothrombin time, fibrinogen prothrombin time, fibrinogen, D-dimer, and C-reactive protein analysis were also conducted.
Results
The average age of patients with severe COVID-19 is higher than of patients with mild COVID-19 ( p = 0.03). The findings showed that fibrinogen, D-dimer, and C-reactive protein were significantly greater in the group of patients with severe COVID-19 ( p = 0.0001). A very strong correlation between the severity of COVID-19 with the D-dimer and C-reactive protein ( p = 0.9) ( p = 0.02) was found.
Conclusion
The results of our study confirm that D-dimer, fibrinogen, and CRP are biomarkers of inflammation and hypercoagulation that serve as predictors of immunothrombosis affecting the severity of COVID-19. D-dimer is also associated with IL10 rs1800872 gene polymorphism in the Kazakh population with severe COVID-19.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Medical University Semey, Semey, Republic of Kazakhstan.
- Department of Tumor and Diagnostic Pathology, Nagasaki University, Nagasaki, Japan.
- High Medical School, Faculty of Medicine and Health Care, Al Farabi Kazakh National University, Almaty, Republic of Kazakhstan.
- Shared Resource Laboratory of Karaganda Medical University, Karaganda, Republic of Kazakhstan.
- Department of Health and Human Resources, Ministry of Health of the Republic of Kazakhstan, Astana, Republic of Kazakhstan.
ORCID-Profile: Assiya Yessenbayeva, Meruyert Massabayeva
Zitieren
APA
Yessenbayeva, A., Apsalikov, B., Massabayeva, M., Kazymov, M., Shakhanova, A., Mussazhanova, Z., Kadyrova, I., Aukenov, N., & Shaimardanov, N. (2023). Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population. PLOS ONE. https://doi.org/10.1371/journal.pone.0288139
Vancouver
Yessenbayeva A, Apsalikov B, Massabayeva M, Kazymov M, Shakhanova A, Mussazhanova Z, et al. Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population. PLOS ONE. 2023. doi:10.1371/journal.pone.0288139
BibTeX
@article{Yessenbayeva2023,
author = {Yessenbayeva, Assiya and Apsalikov, Bakytbek and Massabayeva, Meruyert and Kazymov, Maksut and Shakhanova, Aizhan and Mussazhanova, Zhanna and Kadyrova, Irina and Aukenov, Nurlan and Shaimardanov, Nurlan},
title = {Biomarkers of immunothrombosis and polymorphisms of IL2, IL6, and IL10 genes as predictors of the severity of COVID-19 in a Kazakh population},
journal = {PLOS ONE},
year = {2023},
doi = {10.1371/journal.pone.0288139}
}
EUVIMED